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Introduction
Transurethral resection of the prostate has been 
the gold-standard therapy for lower urinary tract 
symptoms (LUTS) caused by benign prostatic enlarge-
ment (BPE) and benign prostatic obstruction (BPO) 
throughout the world [1–4]. However, during last two 
decades its role has been increasingly challenged by 
the development of several minimally invasive treat-
ment options, including transurethral electrovaporisa-
tion of the prostate [5, 6]. Since its introduction by 
Kramkowsky and Tucker in 1991 and the first reports 
published in 1994, it has been described as a  safe 
and effective treatment for benign prostatic hyperpla-
sia (BPH) [6, 7]. However, several studies have shown 
that the long-term results of electrovaporisation of 
the prostate (EVAP) are worse than of transurethral 
resection of the prostate (TURP) [8, 9]. 
The efficacy of surgical treatment of BHP, includ-
ing the efficacy of TURP and other transurethral 
methods, is evaluated on the basis of improve-
ments in LUTS score and quality of life (QoL), as well 
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A b s t r a c t
Introduction: Transurethral resection of the prostate (TURP) is regarded as the gold standard surgical treatment 
for benign prostatic hyperplasia (BPH). The completeness of TURP may be assessed indirectly by estimation of the 
weight of glandular tissue removed. This parameter is often lower than expected. Tissue vaporisation in the course 
of TURP could be a contributory cause.
Aim: To quantitatively evaluate tissue vaporisation occurring in the course of transurethral resection of the prostate 
and electrovaporisation of the prostate (EVAP) performed under experimental conditions.
Material and methods: The study was performed on 26 prostate glands removed during retropubic prostatectomy. 
Immediately following surgery all adenomas were halved and TURP or EVAP were carried out on both halves of each 
gland for period of 5 min. The amount of prostate tissue which vaporised during EVAP and TURP were calculated.
Results: The mean weight (± standard deviation) of the adenoma lost due to resection and vaporisation in the TURP 
group was 10.00 ±2.92 g and 4.26 ±1.59 g, respectively. The latter accounted for 30.10 ±7.71% of total prostate 
weight reduction. The mean prostate weight lost in the course of EVAP was 5.03 ±1.58 g.
Conclusions: The vaporisation significantly contributes to the prostate tissue loss occurring during transurethral 
resection of the prostate.
Key words: vaporisation, transurethral resection of the prostate, adenoma.
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as improved objective parameters of micturition, 
such as maximal flow rate (Qmax) and post-void 
residual urine volume (PVR) [10]. The completeness 
and efficacy of TURP can also be assessed indirect-
ly by estimation of the weight of glandular tissue 
removed [11, 12]. However, the clinical significance 
of this measure,  as well as its value as a predictor 
of the final response to treatment, has yet to be es-
tablished. 
Several authors have observed significant dis-
crepancies between the amount of resected and ex-
pected tissue during the seemingly complete TURP 
[11, 13–15]. This divergence could likely be attribut-
ed to the process of tissue vaporisation which oc-
curs during TURP, as the procedure involves a rapid 
rise in temperature within the area near the cutting 
electrode which could subsequently result in the tis-
sue vaporisation or carbonisation [16].
A  similar process of tissue vaporisation is in-
volved in transurethral electrovapor resection of the 
prostate (TUVRP), which uses a thick wedge loop al-
lowing for simultaneous vaporisation and resection 
of the gland, and is responsible for approximate-
ly 50% resected tissue weight reduction [17, 18], 
whereas the loss of glandular mass that occurs in 
EVAP is strictly due to tissue vaporisation. 
So far, however, quantitative evaluation of the 
vaporisation process, involved in reduction of pros-
tate adenoma during TURP, has not been performed. 
Aim
The aim of the study was to quantitatively assess 
the amount of glandular tissue lost due to vaporisa-
tion during TURP and compare the efficacy of TURP 
and EVAP techniques under experimental conditions.
Material and methods 
This study was approved by the local research 
ethics committee, and all the procedures have been 
carried out in accordance with the Helsinki Declara-
tion of 1975, as revised in 1983. Twenty six prostate 
glands removed during open prostatectomy (Millin 
method), performed for histologically confirmed 
BPH were included in the study. Immediately follow-
ing surgery all adenomas were halved into two rel-
atively equal parts (left and right lobes) and each of 
them was then weighed. Next, electroresection (ER) 
of one lobe (group 1), and electrovaporisation (EV) of 
the other were carried out for 5 min.
The procedures were performed after the lobes 
of the adenoma had been placed in a 5 l contain-
er exclusively designed for the purpose of the study 
(Photo 1). The dish was equipped with a  passive 
electrode and was filled with 4 l of fluid, obtained 
from a Medsys 20 HP water filter system routinely 
used for transurethral procedures, heated to a tem-
perature of 37°C. The ER was performed using a loop 
electrode from Storz-cutting loop nr. 27040G, while 
EV was done with a cylindrical electrode (Vapotrode, 
Circon-ACMI Corporation, Stamford CT). Diathermic 
current was generated by the ERBE ICC350 appara-
tus – model 3245. For electroresection, a current of 
120 W  was used for cutting and 80 W  for coagu-
lation, whereas vaporesection was performed with 
cutting current of 230 W. Both ER and EV lasted 
5 min each (accuracy of time measurement within 2 s). 
In the course of the procedures, the temperature of 
the water was monitored. 
To prevent drying out of the prostate tissue, the 
resected fragments of the gland, as well as resid-
ual adenoma, were weighed immediately after ER. 
Similarly, immediate weight of the remaining tissue 
was taken following EV. For this purpose a laborato-
ry scale was used, with accuracy to 0.01 g. On the 
basis of these measurements, the total tissue lost 
during ER and EV was determined. After the study, 
the remaining prostate fragments underwent a rou-
tine histopathological examination. 
Photo 1. A container designed for the purpose 
of this study with a passive electrode at its bot-
tom and an active electrode connected to the 
resectoscope loop. The walls of the container 
are made of plexiglass (isolator). The vaporisa-
tion electrode is also visible
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Statistical analysis
Statistical analysis was performed using soft-
ware, the Statistical Package for the Social Sciences 
(SPSS) 12.0 for Windows. Since data in the studied 
groups was distributed in a  Gaussian manner, the 
paired student t-test was applied. A p value of < 0.05 
was considered statistically significant. 
Results
In all of the samples, BPH has been histological-
ly confirmed. Relative to the baseline, an average 
increase of 0.5°C in the water temperature after 
2.5 min and 5 min of ER and EV was observed.
The mean ± standard deviation initial weight of 
adenoma lobes in group 1 and group 2 was 40.61 
±14.48 g and 39.01 ±15.22 g, respectively. There 
was no significant difference between the initial 
weight of the adenomas in both groups (p = 0.759). 
The mean weight of the resected tissue chips in ER 
group was 10.00 ±2.92 g, whilst the mean weight of 
residual adenoma fragments after ER and after EV 
was 26.35 ±13.28 g and 33.98 ±14.60 g, respectively. 
The mean prostate tissue weight lost resulting 
from vaporisation during ER was 4.26 ±1.59 g and 
accounted for 44.58 ±14.60% of the resected frag-
ments’ weight.
The average adenoma weight lost following EVAP 
was 5.03 ±1.58 g. While the mean total weight re-
duction with TURP was statistically greater than 
with EVAP (p < 0.0001, Figure 1), the mean weight 
of vaporised tissue during both TURP and EVAP was 
similar (p = 0.100, Figure 2). All measurements are 
shown in Table I. Table II presents comparison of se-
lected measurements between the two groups un-
der investigation.
Discussion
The significance of the vaporisation phenome-
non in the course of classical transurethral resection 
of the prostate has not yet been thoroughly stud-
ied. This process is innately related to the cutting 
effect of diathermic current [16]. Narayan et al. who 
studied the effect of various physical parameters on 
vaporisation during EVAP and compared the proce-
dure outcomes with those produced by TURP and 
neodymium : yttrium-aluminum-garnet laser fibers, 
reported that electrovaporisation under optimal con-
ditions causes a vaporisation lesion comparable to 
 m EV [g] m reduction EVAP [g]
Mean         Mean ± SE        Mean ± 2 × SD
Figure 2. Comparison of adenoma weight lost 
due to vaporisation following electroresection 
(m EV) vs. total weight reduction after electro-
vaporisation (m reduction EVAP)
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Figure 1. Comparison of total weight reduc-
tion in electoresection group (group 1) vs. total 
weight reduction in electrovaporisation group 
(m reduction EVAP) (group 2). In group 1, to-
tal weight loss is the sum of resected prostate 
chips weight (m r) and the weight of the adeno-
ma lost due to vaporisation (m EV)
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that produced by higher power density laser pros-
tatectomy [19]. In our study, the vaporisation effect 
during TURP resulted in a loss of tissue comprising 
approximately 30% of the total gland weight reduc-
tion. Thus, the vaporisation process seems to play 
a significant role in the reduction of prostate tissue 
during the classical transurethral resection of the 
prostate and should be taken into account while cal-
culating the total amount of removed tissue.
However, the vaporisation effect depends on sev-
eral factors including the technique of the procedure 
as well as various physical parameters of electrosur-
gical generators. The power of the diathermic cur-
rent used in TURP could play a significant role. Pre-
sumably an increase in power would result in more 
intense vaporisation [20]. Moreover, the importance 
of the thickness and number of tissue fragments 
resected with the resectoscope loop should also be 
noted. With full-thickness cuts of tissue the number 
of fragments would be lower compared to when the 
fragments were thinner, and therefore the loss of 
tissue due to vaporisation would be relatively small-
er. In our study, full-thickness tissue cuts were per-
formed and thick fragments were obtained. 
Since the TURP procedure is performed in water 
solution, which under certain conditions can be-
come an electrolyte solution, its chemical composi-
tion may also play a role. However, the significance 
of this effect for transurethral electrosurgery has not 
yet been fully investigated. 
In this study, all procedures were performed in 
an environment without a continuous irrigation fluid 
flow. This could, theoretically, have resulted in ions’ 
concentration changes in the solution, as well as in 
generation of other substances in the course of va-
porisation, which would not occur during EVAP or 
TURP performed in a clinical setting. Hence, the lack 
of analysis, of the chemical composition of the solu-
tion in which the specimens were immersed during 
ER and EV, is a limitation of this study.
In order to achieve the maximal vaporisation ef-
fect in the course of EVAP, it is important to apply an 
adequate pressure with vaporisation electrode onto 
the tissue [21]. In addition, the speed at which the 
vaporisation electrode passes through the prostatic 
Table I. Measurements in electroresection (ER) 
and electrovaporisation (EVAP) groups
Variables N Mean ± standard 
deviation
m pre TURP [g] 26 40.61 ±14.48
m post TURP [g] 26 26.35 ±13.28
m r [g] 26 10.00 ±2.92
m EV [g] 26 4.26 ±1.59
m r + mEV [g] 26 14.26 ±3.75
m EV/m pre TURP × 100 [%] 26 11.24 ±4.15
m EV/m r × 100 [%] 26 44.58 ±14.60
m EV/(mr + mEV) × 100 [%] 26 30.10 ±7.71
m pre EVAP [g] 26 39.01 ±15.22
m post EVAP [g] 26 33.98 ±14.60
m reduction EVAP [g] 26 5.03 ±1.58
m reduction EVAP/m pre 
EVAP × 100 [%]
26 14.56 ±7.31
N – number of glands, m pre TURP – prostate tissue weight prior electrore-
section (group 1), m post TURP – prostate tissue weight after electroresec-
tion, m r – weight of resected tissue chips in ER group, m EV – prostate tissue 
weight reduction secondary to vaporisation occurring during electroresec-
tion (group 1), m r + mEV – total weight reduction following electroresection, 
m EV/m pre TURP × 100 (%) – prostate tissue weight reduction secondary 
to vaporisation occurring during electroresection expressed as the percent of 
pre-electroresection prostate tissue weight, m EV/m r × 100 (%) – prostate 
tissue weight reduction secondary to vaporisation occurring during elect-
roresection expressed as the percent of resected tissue chips in ER group, 
m EV/(m r + mEV) × 100 (%) – prostate tissue weight reduction secondary 
to vaporisation occurring during electroresection expressed as the percent 
of total weight reduction following electroresection, m pre EVAP – prostate 
tissue weight prior electrovaporisation (group 2), m post EVAP – prostate 
tissue weight following electrovaporisation (group 2), m reduction EVAP – 
total weight reduction following electrovaporisation (group 2), m reduction 
EVAP/m pre EVAP × 100 % – total weight reduction following electrovapori-
sation in group 2 expressed as the percent of prostate tissue weight prior 
electrovaporisation.
Table II. Comparison of pre- and post-procedure 
tissue measurements
Variables N Mean ± standard 
deviation
Value of p
m pre TURP 26 40.61 ±14.48 0.759
m pre EVAP 26 39.01 ±15.22
m r + m EV 26 14.26 ±3.75 < 0.0001*
m reduction EVAP 26 5.03 ±1.58
m EV 26 4.26 ±1.59 0.100
m reduction EVAP 26 5.03 ±1.58
*Statistically significant, N – number of glands, m pre TURP – prostate tissue 
weight prior electroresection (group 1), m pre EVAP – prostate tissue weight 
prior electrovaporisation (group 2), m r – weight of resected tissue chips in 
ER group, m EV – prostate tissue weight reduction secondary to vaporisation 
occurring during electroresection (group 1), m r + m EV – total weight reduc-
tion following electroresection, m reduction EVAP – total weight reduction 
following electrovaporisation, m EV – prostate tissue weight reduction sec-
ondary to vaporisation occurring during electroresection
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segment of the urethra plays a  role, with maximal 
vaporisation effect occurring at a slow pass rate, not 
greater than 10 mm/s [21]. These parameters were 
not standardised during the EVAP performed under 
experimental conditions, which is another limitation 
of this study. However, continuous macroscopic eval-
uation of the vaporisation effect occurring during 
procedures made it possible to gauge the speed of 
the electrode, so that the measured effect would 
have been optimal. 
Conclusions
This study demonstrates that the reduction of ade-
noma tissue due to vaporisation in the course of TURP 
could be significant, and should be accounted for in 
the total reduced weight calculation. The EVAP pro-
cedure causes a similar loss of adenoma tissue com-
parable to that obtained through vaporisation during 
TURP. Further research should assess impact of poten-
tially modifiable factors on vaporisation effect occur-
ring during transurethral resection of the prostate.
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